Ameriprise’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.59M Buy
194,037
+13,902
+8% +$244K ﹤0.01% 2646
2025
Q4
$2.81M Sell
180,135
-1,196
-0.7% -$17.1K ﹤0.01% 2819
2025
Q3
$2.65M Sell
181,331
-82,761
-31% -$1.23M ﹤0.01% 2857
2025
Q2
$4.08M Buy
264,092
+179,108
+211% +$2.65M ﹤0.01% 2512
2025
Q1
$1.26M Buy
84,984
+19,861
+30% +$278K ﹤0.01% 3108
2024
Q4
$862K Sell
65,123
-9,169
-12% -$126K ﹤0.01% 3310
2024
Q3
$1.06M Buy
74,292
+19,704
+36% +$279K ﹤0.01% 3198
2024
Q2
$706K Sell
54,588
-31,850
-37% -$422K ﹤0.01% 3311
2024
Q1
$1.2M Buy
86,438
+4,945
+6% +$71.9K ﹤0.01% 3096
2023
Q4
$1.16M Buy
81,493
+1,030
+1% +$14.6K ﹤0.01% 3126
2023
Q3
$1.24M Buy
80,463
+4,353
+6% +$67.4K ﹤0.01% 3046
2023
Q2
$1.2M Buy
76,110
+3,205
+4% +$52.5K ﹤0.01% 3095
2023
Q1
$1.2M Sell
72,905
-25,918
-26% -$413K ﹤0.01% 3073
2022
Q4
$1.54M Sell
98,823
-12,959
-12% -$181K ﹤0.01% 2920
2022
Q3
$1.45M Buy
111,782
+51,917
+87% +$722K ﹤0.01% 2943
2022
Q2
$840K Sell
59,865
-20,818
-26% -$297K ﹤0.01% 3191
2022
Q1
$1.16M Buy
80,683
+16,097
+25% +$236K ﹤0.01% 3149
2021
Q4
$885K Sell
64,586
-8,316
-11% -$117K ﹤0.01% 3313
2021
Q3
$1.19M Buy
72,902
+10,637
+17% +$179K ﹤0.01% 3093
2021
Q2
$1.05M Buy
62,265
+1,508
+2% +$25.7K ﹤0.01% 3204
2021
Q1
$1.11M Buy
60,757
+16,482
+37% +$297K ﹤0.01% 3103
2020
Q4
$807K Sell
44,275
-13,750
-24% -$241K ﹤0.01% 3181
2020
Q3
$1.03M Sell
58,025
-125,318
-68% -$2.28M ﹤0.01% 2953
2020
Q2
$3.29M Buy
183,343
+137,989
+304% +$2.48M ﹤0.01% 2345
2020
Q1
$688K Sell
45,354
-430
-0.9% -$7.79K ﹤0.01% 2985
2019
Q4
$904K Sell
45,784
-3,749
-8% -$71.7K ﹤0.01% 3099
2019
Q3
$851K Sell
49,533
-5,219
-10% -$90.3K ﹤0.01% 3085
2019
Q2
$969K Sell
54,752
-70,307
-56% -$1.28M ﹤0.01% 3082
2019
Q1
$2.55M Buy
125,059
+12,069
+11% +$243K ﹤0.01% 2625
2018
Q4
$1.9M Buy
+112,990
New +$1.91M ﹤0.01% 2669

Other funds holding TAK